NYSE: AZN
Astrazeneca PLC Stock Ownership - Who owns Astrazeneca?

Insider buying vs selling

Have Astrazeneca PLC insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Mani SharmaSVP Group Controller and Head of Global Finance Services2026-06-081$179.75
$179.75Buy
Mani SharmaSVP Group Controller and Head of Global Finance Services2026-05-2011,893$185.78
$2.21MSell
Mani SharmaSVP Group Controller and Head of Global Finance Services2026-05-061$186.28
$186.28Buy
Mani SharmaSVP Group Controller and Head of Global Finance Services2026-04-071$196.03
$196.03Buy

1 of 1

AZN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AZN insiders and whales buy or sell their stock.

AZN Shareholders

What type of owners hold Astrazeneca PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Investor Ab3.33%51,587,810$9.22BInstitution
Vanguard Capital Management LLC2.91%45,040,142$8.05BInstitution
Capital International Investors2.22%34,393,013$6.15BInstitution
Fmr LLC1.91%29,601,724$5.29BInstitution
Capital World Investors1.82%28,264,580$5.05BInstitution
Legal General Group PLC1.67%25,849,978$4.62BInstitution
Wellington Management Group LLP1.53%23,751,085$4.24BInstitution
Price T Rowe Associates Inc1.26%19,489,220$3.48BInstitution
Bank Of America Corp1.23%19,058,327$3.41BInstitution
Jpmorgan Chase Co1.20%18,590,922$3.32BInstitution

1 of 3

AZN vs General Drug Manufacturer Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AZN48.99%0.00%Net SellingNet Selling
MRK78.10%0.22%Net BuyingNet Buying
NVS7.63%0.00%
AMGN79.32%1.01%Net SellingNet Selling
ABBV73.59%0.16%Net Selling

Astrazeneca Stock Ownership FAQ

Who owns Astrazeneca?

Astrazeneca (NYSE: AZN) is owned by 48.99% institutional shareholders, 0.00% Astrazeneca insiders, and 51.00% retail investors. Investor Ab is the largest individual Astrazeneca shareholder, owning 51.59M shares representing 3.33% of the company. Investor Ab's Astrazeneca shares are currently valued at $9.18B.

If you're new to stock investing, here's how to buy Astrazeneca stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.